Veit Michael Stoecklein1, Lars Kellert2, Maximilian Patzig3, Clemens Küpper2, Armin Giese4, Viktoria Ruf4, Jonathan Weller1, Friedrich-Wilhelm Kreth1, Florian Schöberl5. 1. Department of Neurosurgery, Ludwig-Maximilians-University Munich, Munich, Germany. 2. Department of Neurology, Ludwig-Maximilians-University Munich, Marchioninistr.15, 81377, Munich, Germany. 3. Department of Neuroradiology, Ludwig-Maximilians-University Munich, Munich, Germany. 4. Center for Neuropathology and Prion Research, Ludwig-Maximilians-University Munich, Munich, Germany. 5. Department of Neurology, Ludwig-Maximilians-University Munich, Marchioninistr.15, 81377, Munich, Germany. Florian-Schoeberl@med.uni-muenchen.de.
Abstract
OBJECTIVE: To evaluate the diagnostic accuracy and safety of extended stereotactic brain biopsy (ESBB) in a single center cohort with suspected primary angiitis of the central nervous system (PACNS). METHODS: A standardized stereotactic biopsy targeting MRI-positive lesions and collecting samples from the meninges and the cortex as well as from the white matter was performed in 23 patients with clinically suspected PACNS between 2010 and 2017. The relationship between biopsy yield and clinical characteristics, cerebrospinal fluid parameters, MR-imaging, time point of biopsy and exact localization of biopsy as well as number of tissue samples were examined. RESULTS: PACNS was confirmed in 7 of 23 patients (30.4%). Alternative diagnoses were identified in 7 patients (30%). A shorter time period between the onset or worsening of symptoms (p = 0.018) and ESBB significantly increased the diagnostic yield. We observed only minor and transient postoperative complications in 3 patients (13.0%). ESBB led to a direct change of the therapeutic regime in 13 of 23 patients (56.5%). Careful neuropathological analysis furthermore revealed that cortical samples were crucial in obtaining a diagnosis. CONCLUSION: ESBB is a safe approach with good feasibility, even in critically ill patients, and high diagnostic accuracy in patients with suspected PACNS changing future therapies in 13 of 23 patients (56.5%). Early biopsy after symptom onset/worsening is crucial and (sub)acute MRI-lesions should be targeted with a particular need for biopsy samples from the cortical layer.
OBJECTIVE: To evaluate the diagnostic accuracy and safety of extended stereotactic brain biopsy (ESBB) in a single center cohort with suspected primary angiitis of the central nervous system (PACNS). METHODS: A standardized stereotactic biopsy targeting MRI-positive lesions and collecting samples from the meninges and the cortex as well as from the white matter was performed in 23 patients with clinically suspected PACNS between 2010 and 2017. The relationship between biopsy yield and clinical characteristics, cerebrospinal fluid parameters, MR-imaging, time point of biopsy and exact localization of biopsy as well as number of tissue samples were examined. RESULTS: PACNS was confirmed in 7 of 23 patients (30.4%). Alternative diagnoses were identified in 7 patients (30%). A shorter time period between the onset or worsening of symptoms (p = 0.018) and ESBB significantly increased the diagnostic yield. We observed only minor and transient postoperative complications in 3 patients (13.0%). ESBB led to a direct change of the therapeutic regime in 13 of 23 patients (56.5%). Careful neuropathological analysis furthermore revealed that cortical samples were crucial in obtaining a diagnosis. CONCLUSION:ESBB is a safe approach with good feasibility, even in critically illpatients, and high diagnostic accuracy in patients with suspected PACNS changing future therapies in 13 of 23 patients (56.5%). Early biopsy after symptom onset/worsening is crucial and (sub)acute MRI-lesions should be targeted with a particular need for biopsy samples from the cortical layer.
Entities:
Keywords:
Brain biopsy; Cerebral vasculitis; Image-guided neurosurgery; Primary angiitis of the central nervous system; Stereotactic neurosurgery; Stroke
Authors: Jonas Graf; Jan Claudius Schwitalla; Philipp Albrecht; Roland Veltkamp; Peter Berlit; Hans-Peter Hartung; Orhan Aktas; Markus Kraemer Journal: J Neurol Date: 2019-02-25 Impact factor: 4.849
Authors: J Becker; P A Horn; K Keyvani; I Metz; C Wegner; W Brück; F M Heinemann; J C Schwitalla; P Berlit; M Kraemer Journal: Clin Neurol Neurosurg Date: 2017-03-08 Impact factor: 1.876
Authors: Carlo Salvarani; Robert D Brown; Kenneth T Calamia; Teresa J H Christianson; Stephen D Weigand; Dylan V Miller; Caterina Giannini; James F Meschia; John Huston; Gene G Hunder Journal: Ann Neurol Date: 2007-11 Impact factor: 10.422
Authors: Maximilian Patzig; Robert Forbrig; Clemens Küpper; Ozan Eren; Tobias Saam; Lars Kellert; Thomas Liebig; Florian Schöberl Journal: J Neurol Date: 2021-07-08 Impact factor: 4.849